Categories
Advocates & Activists BS & The Quackery Divergent News

Leah Remini claims she still receives threats from the Church of Scientology | Fox News

Leah Remini claims she still receives threats from the Church of Scientology even after her docuseries “Scientology and the Aftermath” launched in 2016 on A&E. Source: Leah Remini claims she still receives threats from the Church of Scientology | Fox News

Categories
Advocates & Activists BS & The Quackery Divergent News

Leah Remini Still Gets Threats From Church of Scientology

Leah Remini talks getting ‘threats’ from the Church of Scientology — find out more! Source: Leah Remini Still Gets Threats From Church of Scientology

Categories
Aging & Disability Divergent News Employment & Education Healthcare & Wellness

Down syndrome left this Carmel teen with few jobs. So his dad started ‘Sky Boxes’

Sky Simpson now has two things his dad feared he never would: A best friend and promising career. Source: Down syndrome left this Carmel teen with few jobs. So his dad started ‘Sky Boxes’

Categories
Cannabis Divergent News Healthcare & Wellness

Saint Vincent And The Grenadines Decriminalizes Marijuana

Look out Jamaica, SVG islands race for cannabis cultivation and foreign investment. Source: Saint Vincent And The Grenadines Decriminalizes Marijuana

Categories
Cannabis Divergent News Healthcare & Wellness

These States Are Most Likely To Legalize Marijuana In 2019

After a slew of victories for marijuana reformers in 2018, several more states are posed to legalize cannabis in the new year. Source: These States Are Most Likely To Legalize Marijuana In 2019

Categories
Aging & Disability Divergent News Healthcare & Wellness

Meet the Teenage Girl Who Is Allergic to Almost Everything: ‘I Want My Old Life Back’

McKenze Messman Is Allergic to Almost Everything Source: Meet the Teenage Girl Who Is Allergic to Almost Everything: ‘I Want My Old Life Back’

Categories
Aging & Disability Divergent News Healthcare & Wellness

Acer Therapeutics Announces FDA Acceptance of NDA and Priority Review for EDSIVO™ for the Treatment of vEDS

Acer continues progress toward goal of commercializing EDSIVO™ NEWTON, Mass., Dec. 26, 2018 (GLOBE NEWSWIRE) — Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and ultra-rare diseases with critical unmet medical need, today announced that the U.S. Food and Drug Administration (FDA) has […]